BC
RGEN icon

Bartlett & Co’s Repligen RGEN Stock Holding History

Bartlett & Co’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,450
Closed -$179K – 851
2020
Q2 		$179K Hold
1,450
– – ﹤0.01% 324
2020
Q1 		$140K Buy
+1,450
New +$140K ﹤0.01% 323
2019
Q3 		$111K Hold
1,450
– – ﹤0.01% 390
2019
Q2 		$125K Hold
1,450
– – ﹤0.01% 299
2019
Q1 		$86K Hold
1,450
– – ﹤0.01% 337
2018
Q4 		$76K Hold
1,450
– – ﹤0.01% 345
2018
Q3 		$80K Hold
1,450
– – ﹤0.01% 353
2018
Q2 		$68K Hold
1,450
– – ﹤0.01% 385
2018
Q1 		$52K Hold
1,450
– – ﹤0.01% 421
2017
Q4 		$53K Hold
1,450
– – ﹤0.01% 425
2017
Q3 		$56K Hold
1,450
– – ﹤0.01% 421
2017
Q2 		$60K Hold
1,450
– – ﹤0.01% 414
2017
Q1 		$51K Buy
+1,450
New +$45.9K ﹤0.01% 430

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bartlett & Co's RGEN Position: Q3 2020 in Review

Bartlett & Co sold out of Repligen (RGEN) in Q3 2020, closing a stake of 1,450 shares — an estimated $179K sold.

Bartlett & Co first reported a position in RGEN in Q1 2017 and held it in 13 quarters. The position peaked at $179K in Q2 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Bartlett & Co reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Bartlett & Co sold 1,450 Repligen shares in Q3 2020, an estimated $179K.
  • Bartlett & Co first reported a position in Repligen in Q1 2017 and held it in 13 quarters.
  • Bartlett & Co's Repligen position peaked at $179K in Q2 2020.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Bartlett & Co's 13F filing for Q3 2020, filed 20 Oct 2020.